Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Slayback Pharma
301 Carnegie Center, #303
Princeton, NJ 08540
Phone: 609-945-3443
http://www.slayback-pharma.com/

Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and Europe. Since its inception in 2011, Slayback has demonstrated a spectacular track record of numerous sole first-to-file ANDAs, 505(b)(2)s and complex generic filings, approvals and launches. In the past year, Slayback's ANDA for Hydroxyprogesterone 5 ml vial was the first generic ANDA to be approved and launched in the U.S., and Slayback continues to hold the largest market share.

Key Contact
Name
Ajay Singh
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/06/20 $50,000,000 Series B Everstone
undisclosed